Author:
Fazelpour Sherwin,Gibson Frederick,Caligayahan Marian,Vashi Neelam
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Nazzaro G, Buffon S, Giacalone S, Maronese CA, Marzano AV (2022) Skin manifestations associated with checkpoint inhibitors. JEADV Clin Pract 1:73–87
2. LiverTox Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury
3. Ingen-Housz-Oro S, Milpied B, Badrignans M, Carrera C, Elshot YS, Bensaid B et al (2022) Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases. Melanoma Res 32:205–210
4. Maloney NJ, Ravi V, Cheng K, Bach DQ, Worswick S (2020) Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review. Int J Dermatol 59:e183–e188
5. Thompson JA, Schneider BJ, Brahmer J, Achufusi A, Armand P, Berkenstock MK et al (2022) Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20:387–405